000 | 01880 a2200553 4500 | ||
---|---|---|---|
005 | 20250516065530.0 | ||
264 | 0 | _c20120312 | |
008 | 201203s 0 0 eng d | ||
022 | _a1465-3621 | ||
024 | 7 |
_a10.1093/jjco/hyr176 _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aShinohara, Nobuo | |
245 | 0 | 0 |
_aInterferon-α-based immunotherapy in metastatic renal cell carcinoma patients with the primary tumor in situ. _h[electronic resource] |
260 |
_bJapanese journal of clinical oncology _cFeb 2012 |
||
300 |
_a113-9 p. _bdigital |
||
500 | _aPublication Type: Journal Article | ||
650 | 0 | 4 | _aAdult |
650 | 0 | 4 | _aAged |
650 | 0 | 4 | _aAged, 80 and over |
650 | 0 | 4 |
_aAntineoplastic Combined Chemotherapy Protocols _xtherapeutic use |
650 | 0 | 4 |
_aCarcinoma in Situ _xdrug therapy |
650 | 0 | 4 |
_aCarcinoma, Renal Cell _xdrug therapy |
650 | 0 | 4 | _aChemotherapy, Adjuvant |
650 | 0 | 4 |
_aCimetidine _xadministration & dosage |
650 | 0 | 4 |
_aDexamethasone _xadministration & dosage |
650 | 0 | 4 | _aFemale |
650 | 0 | 4 | _aHumans |
650 | 0 | 4 |
_aImmunotherapy _xmethods |
650 | 0 | 4 |
_aInterferon-alpha _ximmunology |
650 | 0 | 4 | _aKaplan-Meier Estimate |
650 | 0 | 4 |
_aKidney Neoplasms _xdrug therapy |
650 | 0 | 4 | _aMale |
650 | 0 | 4 | _aMeloxicam |
650 | 0 | 4 | _aMiddle Aged |
650 | 0 | 4 |
_aNeoadjuvant Therapy _xmethods |
650 | 0 | 4 | _aNephrectomy |
650 | 0 | 4 |
_aThiazines _xadministration & dosage |
650 | 0 | 4 |
_aThiazoles _xadministration & dosage |
650 | 0 | 4 | _aTreatment Outcome |
700 | 1 | _aAbe, Takashige | |
700 | 1 | _aSazawa, Ataru | |
700 | 1 | _aMaruyama, Satoru | |
700 | 1 | _aShindo, Junri | |
700 | 1 | _aSato, Soshu | |
700 | 1 | _aSuzuki, Shin | |
700 | 1 | _aNonomura, Katsuya | |
773 | 0 |
_tJapanese journal of clinical oncology _gvol. 42 _gno. 2 _gp. 113-9 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.1093/jjco/hyr176 _zAvailable from publisher's website |
999 |
_c21356882 _d21356882 |